Managing Side Effects of Angiogenesis Inhibitors in Renal Cell Carcinoma
Author:
Publisher
S. Karger AG
Subject
Cancer Research,Oncology,Hematology
Reference19 articles.
1. The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
2. Tumour suppression by the human von Hippel-Lindau gene product
3. Targeted Approaches for Treating Advanced Clear Cell Renal Carcinoma
4. Sunitinib: From Rational Design to Clinical Efficacy
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PIDiff: Physics informed diffusion model for protein pocket-specific 3D molecular generation;Computers in Biology and Medicine;2024-09
2. Tyrosine kinase inhibitors as next generation oncological therapeutics: Current strategies, limitations and future perspectives;Therapies;2021-11
3. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice;Journal of Controlled Release;2018-12
4. Design, synthesis and biological evaluation of indolin-2-one-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase3 (FLT3);European Journal of Medicinal Chemistry;2017-02
5. In Vitro and In Vivo Evaluation of Targeted Sunitinib-Loaded Polymer Microbubbles Against Proliferation of Renal Cell Carcinoma;Journal of Ultrasound in Medicine;2016-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3